1. Home
  2. BIVI vs BKYI Comparison

BIVI vs BKYI Comparison

Compare BIVI & BKYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioVie Inc.

BIVI

BioVie Inc.

HOLD

Current Price

$1.09

Market Cap

9.2M

Sector

Health Care

ML Signal

HOLD

Logo BIO-key International Inc.

BKYI

BIO-key International Inc.

HOLD

Current Price

$0.67

Market Cap

8.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIVI
BKYI
Founded
2013
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
8.3M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
BIVI
BKYI
Price
$1.09
$0.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
95.9K
9.2M
Earning Date
02-09-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,316,050.00
Revenue This Year
N/A
$7.45
Revenue Next Year
N/A
$23.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.06
$0.51
52 Week High
$20.40
$1.97

Technical Indicators

Market Signals
Indicator
BIVI
BKYI
Relative Strength Index (RSI) 35.44 51.39
Support Level $1.11 $0.63
Resistance Level $1.29 $0.80
Average True Range (ATR) 0.08 0.07
MACD -0.00 0.01
Stochastic Oscillator 0.00 38.98

Price Performance

Historical Comparison
BIVI
BKYI

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About BKYI BIO-key International Inc.

BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.

Share on Social Networks: